Pharmaceuticals & Drugs
|Market Cap||6,063 Cr||EPS||4.9||High||390.5|
|Stock P/E||77.6||Net Profit Margin||3.2||Low||374.95|
Jubilant Pharmova Price chart
|Market Cap||6,063 Cr||ROE||8.4%|
|P/B Ratio||2.5||Dividend Yield||1.3%|
|Industry P/E||63.6||Book Value||153.6|
About the Company
Jubilant Life Sciences (formerly Jubilant Organosys) was incorporated in the year 1978. It’s a public limited company domiciled in India and incorporated under the provisions of Companies Act, 1956. Its shares are listed on BSE Limited and National Stock Exchange of India Limited.
The Pharmaceuticals segment, through its wholly-owned subsidiary Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six USFDA approved manufacturing facilities in the US, Canada and India and a network of various radiopharmacies in the US.
The Life Science Ingredients segment is engaged in specialty intermediates, nutritional products and life science chemicals through five manufacturing facilities in India. The drug discovery solutions business is served by Jubilant Biosys and the India branded pharmaceuticals business is an Indian venture with a range of pharmaceutical offerings for the domestic market, focusing primarily on products to treat medical conditions in the field of cardiology and diabetology.
Business area of the company
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals.
|Parent Organisation||Jubilant Pharmova Ltd.||Managing Director||Hari S Bhartia|
All values are in Rs Cr
|Company||52 Week||Market Price||P/E Ratio|
Frequently asked questions